Michael J Brennan

Bio

Dr. Michael Brennan was previously a General Partner at Oxford Bioscience Partners. Prior to that, he was President and Chief Executive Officer of Gene Logic (NASDAQ: GLGC). During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion. He raised three rounds of venture capital and led Gene Logic to an IPO in November, 1997 and a large secondary public offering in January, 2000. Dr. Brennan’s previous experience includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer Mannheim Therapeutics. Dr. Brennan received a B.S. in Biochemistry, a Ph.D. in neurobiology and a M.D. from the University of Witwatersrand, Johannesburg, South Africa.